Oral LSD Drug Hits Phase III Endpoints In Anxiety, Depression
Definium says its single-dose oral LSD formulation met primary endpoints in two Phase III trials; the results have not yet established approval or long-term safety.
Obesity Drugs May Help Protect Memory And Cognitive Abilities
A Science review examines whether GLP-1 obesity drugs could protect cognition, while human evidence remains mixed and Alzheimer’s trials were negative.